■比较局部麻醉开始后施用粘膜下地塞米松(4mg)对第三磨牙手术后术后不适的影响,并将参数与未接受药物的对照组进行比较。
■总共有60例患者需要手术切除下颌阻生第三磨牙(近中角,II类或III类,位置B或C)随机分为两组,每组30例。局部麻醉开始后,第一组(A组)在手术部位附近接受了4mg地塞米松的粘膜下注射,对照组(B组)不接受药物治疗。疼痛,肿胀,在1日的随访中记录了刺耳,2nd,术后第7天。术后不适的评估是通过改良的术后症状严重程度量表问卷评估反应来进行的。在术后第7天给予患者。
■两组之间主观疼痛值和平均消耗的镇痛药数量的差异不显著。术后1日肿胀差异有统计学意义,第二个(P<0.0001),术后第7天(P=0.0152)。在术后第1天和第2天,术后三联子的差异非常显着(P<0.0001)。平均总生活质量(QOL)评分的差异,吃,外观,每日活动分量表(P<0.0001),和社会隔离子量表(P=0.0002)在两组之间具有统计学意义。
■发现粘膜下地塞米松的给药导致术后肿胀和三眼明显减轻,生活质量更好。
UNASSIGNED: To compare the impact of submucosal dexamethasone (4 mg) administered after the onset of local anesthesia on postoperative discomfort after third molar surgery and compare the parameters with a control group that did not receive the drug.
UNASSIGNED: A total of 60 patients indicated for surgical removal of impacted mandibular third molars (mesioangular, Class II or III, and position B or C) were randomly divided into two groups of 30 patients each. After the onset of local anesthesia, the first group (Group A) received a submucosal injection of 4 mg dexamethasone adjacent to the surgical site, and the control group (Group B) received no drug. Pain, swelling, and trismus were recorded at follow-up visits on the 1st, 2nd, and 7th postoperative days. Assessment of postoperative discomfort was performed by evaluating responses through a modified postoperative symptom severity scale questionnaire, which was administered to the patients on the 7th postoperative day.
UNASSIGNED: The difference in subjective pain values and the mean number of analgesics consumed was not significant between the groups. The difference in postoperative swelling was statistically significant on the 1st, 2nd (P < 0.0001), and 7th postoperative days (P = 0.0152). The difference in postoperative trismus was highly significant on 1st and 2nd postoperative days (P < 0.0001). The difference in the mean total quality of life (QOL) score, Eating, Appearance, Daily activity subscale (P < 0.0001), and Social Isolation subscale (P = 0.0002) was statistically significant between both groups.
UNASSIGNED: It was found that the administration of submucosal dexamethasone resulted in significantly lesser postoperative swelling and trismus and better QOL outcomes.